BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 12, 2007
View Archived Issues
Swedish Study Finds Molecular Cause For Kidney Infections
Read More
Aptuit Paying $64M For Evotec Chemistry Unit
Read More
Antisoma's Lung Cancer Drug Repeats Strong Phase II Results
Read More
Biotech Fears Tough Restrictions From EU On Use of Primates
Read More
Nanobody Alliance With BI Could Net €200M For Ablynx
No Abstract
Read More
FDA OKs TopoTarget's Totect For Extravasation Treatment
Read More
Other News To Note
Read More
BioAlliance Launches Loramyc; Pleased With Pricing Directive
Read More
Business and Academia Merge In UK-Australia Partnership
Read More
UK Opens Door to Work With Hybrid Embryos
LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International)
Read More
MediGene Gets $21M In Private Share Placement
Read More